Skip to content

A Study Comparing Ceramic-on-metal Articulation to Metal-on-metal Articulation in Cementless Primary Hip Arthroplasty

A Multi-center Prospective Randomized Control Trial to Compare Two Articulating Bearing Surfaces, Ceramic-on-metal and Metal-on-metal as Used in Cementless Primary Hip Arthroplasty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00754520
Enrollment
213
Registered
2008-09-18
Start date
2009-05-31
Completion date
2021-12-31
Last updated
2024-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Brief summary

The aim of this study is to demonstrate the non-inferiority of the ceramic on metal articulation using M2a-38™ mm cup compared to the metal on metal articulation using the same cup.

Detailed description

The aim of this study is to demonstrate the non-inferiority of the ceramic on metal articulation using M2a-38™ mm cup compared to the metal on metal articulation using the same cup in regards to the composite clinical success (CCS) rate, as defined in the protocol, at 2 year postoperative.

Interventions

DEVICECeramic On Metal

Ceramic on Metal articulation using M2a-38™ mm cup

DEVICEMetal on Metal

Metal on Metal articulation using M2a-38™ mm cup

Sponsors

Zimmer Biomet
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients presenting with osteoarthritis and suitable for primary Total Hip Replacement * Patients preoperative Harris Hip Score \<= 70 points * Patients aged over 18 and under 75 * Patients with limited co-morbidity - ASA I-III * Patients with normal urea and electrolyte levels and creatinine levels * Patients must be able to understand instructions and be willing to return for follow-up * Patients willing to provide blood and urine samples for metal ion analysis at follow up

Exclusion criteria

* Patients preoperative Harris Hip Score \> 70 points * Previous prosthetic hip surgery * Patients with significant co-morbidity - ASA IV - V * Dementia and inability to understand and follow instructions * Neurological conditions affecting movement * Existing metal implant or fixation device * Pregnancy * Presence of symptomatic arthritis in other lower limb joints

Design outcomes

Primary

MeasureTime frameDescription
Composite Clinical Success (CCS) Rate as Defined in the Protocol2 years post-operativelyCCS is defined as: a. Total Harris Hip Score \> 80 points, and b. No acetabular or femoral revision or removal, and c. No pending acetabular or femoral revision or removal as defined in radiographic evaluation by: i. An acetabular radiographic assessment with all of the following: 1. Migration \< 4 mm, and 2. Change in angle of inclination \< 4o, and 3. Absence of osteolysis, and ii. A femoral radiographic assessment with all of the following: 1\. Subsidence \< 5 mm, and 2. Absence of osteolysis. The HHS including a series of questions answered by the patient and physical examinations recorded by a qualified health care professional covers four domains: pain (one item, 0-44 points), function and functional activities (seven items, 0-47 points), absence of deformity (one item, 0-4 points) and range of motion (one item, 0-5 points). To obtain a final score, the points are summed. The outcome score can be categorized as Excellent: 90-100; Good: 80-90; Fair: 70-80; Poor: \< 70

Secondary

MeasureTime frameDescription
Oxford Hip Scorepre-operatively, 6 weeks post-operatively, 6 months post-operatively, 1, 2, 3, 4, 5 and 10 years post-operativelyThe Oxford Hip Score (OHS) is a patient-reported outcome measure that was developed to specifically assess the patient's perspective of outcome following THA. The OHS consists of twelve questions covering function and pain associated with the hip. To calculate the total score, each response is scored from 0 (worst outcome) to 4 (best outcome) and the sum of all 12 items is reported with a maximum of 48, representing the best score possible. The outcome score can be categorized as Excellent: \> 41; Good: 34 - 41; Fair: 27 - 33; Poor: \< 27.
Womac Scorepre-operatively, 6 weeks post-operatively, 6 months post-operatively, 1, 2, 3, 4, 5 and 10 years post-operativelyThe Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC score) is a standardised patient reported outcome measure consisting of 24 items divided into 3 sub-sections: Pain (5 items), stiffness (2 items) and physical function or Activities of Daily Living; ADL (17 items). A higher score indicates a worse clinical outcome. The maximum score for each subsection is Pain: 20 - 0; Stiffness: 8 - 0; ADL: 68 - 0.
Metal Ion Concentrations in Blood6 months post-operatively, 1, 2, 3 and 5 years post-operativelyChromium and Cobalt concentrations in blood are measured in measurement unit nmol/L. The change from baseline analysis is presented.
Survivorship10 years post-opSurvival of the implant based on the removal or intended removal of the device. The percentage of patients that still have the implant 10 years post-operative is presented here.

Countries

Finland, United Kingdom

Participant flow

Participants by arm

ArmCount
Ceramic On Metal
Patients that underwent total hip arthroplasty, who received a M2a-38mm cup and the Biolox delta 38 mm ceramic femoral head.
111
Metal on Metal
Patients that underwent total hip arthroplasty, who received a M2a-38mm cup and the 38 mm cobalt chromium molybdenum (CoCrMo) modular femoral head.
102
Total213

Baseline characteristics

CharacteristicCeramic On MetalMetal on MetalTotal
Age, Continuous65.2 years
STANDARD_DEVIATION 7
65.3 years
STANDARD_DEVIATION 7.2
65.2 years
STANDARD_DEVIATION 7.1
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Finland
30 participants22 participants52 participants
Region of Enrollment
United Kingdom
81 participants80 participants161 participants
Sex: Female, Male
Female
38 Participants40 Participants78 Participants
Sex: Female, Male
Male
73 Participants62 Participants135 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
16 / 11013 / 101
other
Total, other adverse events
0 / 1100 / 101
serious
Total, serious adverse events
35 / 11038 / 101

Outcome results

Primary

Composite Clinical Success (CCS) Rate as Defined in the Protocol

CCS is defined as: a. Total Harris Hip Score \> 80 points, and b. No acetabular or femoral revision or removal, and c. No pending acetabular or femoral revision or removal as defined in radiographic evaluation by: i. An acetabular radiographic assessment with all of the following: 1. Migration \< 4 mm, and 2. Change in angle of inclination \< 4o, and 3. Absence of osteolysis, and ii. A femoral radiographic assessment with all of the following: 1\. Subsidence \< 5 mm, and 2. Absence of osteolysis. The HHS including a series of questions answered by the patient and physical examinations recorded by a qualified health care professional covers four domains: pain (one item, 0-44 points), function and functional activities (seven items, 0-47 points), absence of deformity (one item, 0-4 points) and range of motion (one item, 0-5 points). To obtain a final score, the points are summed. The outcome score can be categorized as Excellent: 90-100; Good: 80-90; Fair: 70-80; Poor: \< 70

Time frame: 2 years post-operatively

Population: Due to a lack of radiographic evaluation data, the overall number of participants analyzed is smaller than the actual number enrolled.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Ceramic On MetalComposite Clinical Success (CCS) Rate as Defined in the Protocol59 Participants
Metal on MetalComposite Clinical Success (CCS) Rate as Defined in the Protocol63 Participants
Secondary

Metal Ion Concentrations in Blood

Chromium and Cobalt concentrations in blood are measured in measurement unit nmol/L. The change from baseline analysis is presented.

Time frame: 6 months post-operatively, 1, 2, 3 and 5 years post-operatively

Population: Metal Ion analysis is only performed on a subset of the patients. Other than that, the number of participants fluctuates over time due to several reasons, such as missing visits or lost to follow-up or withdrawn from the study for any reason.

ArmMeasureGroupValue (MEAN)Dispersion
Ceramic On MetalMetal Ion Concentrations in BloodCobalt 6 months8.8 nmol/lStandard Deviation 8.7
Ceramic On MetalMetal Ion Concentrations in BloodChromium 2 years1.4 nmol/lStandard Deviation 13.9
Ceramic On MetalMetal Ion Concentrations in BloodCobalt 1 year16.3 nmol/lStandard Deviation 28.3
Ceramic On MetalMetal Ion Concentrations in BloodChromium 1 year1.5 nmol/lStandard Deviation 25.4
Ceramic On MetalMetal Ion Concentrations in BloodCobalt 2 years12.3 nmol/lStandard Deviation 18.2
Ceramic On MetalMetal Ion Concentrations in BloodChromium 3 years-15.3 nmol/lStandard Deviation 7.3
Ceramic On MetalMetal Ion Concentrations in BloodCobalt 3 years13.0 nmol/lStandard Deviation 19.6
Ceramic On MetalMetal Ion Concentrations in BloodChromium 5 years8.9 nmol/lStandard Deviation 29.3
Ceramic On MetalMetal Ion Concentrations in BloodCobalt 5 years17.7 nmol/lStandard Deviation 46.4
Ceramic On MetalMetal Ion Concentrations in BloodChromium 6 months-1.8 nmol/lStandard Deviation 16.9
Metal on MetalMetal Ion Concentrations in BloodCobalt 5 years64.9 nmol/lStandard Deviation 64
Metal on MetalMetal Ion Concentrations in BloodChromium 6 months1.9 nmol/lStandard Deviation 15.3
Metal on MetalMetal Ion Concentrations in BloodChromium 1 year17.5 nmol/lStandard Deviation 32.5
Metal on MetalMetal Ion Concentrations in BloodChromium 2 years18.8 nmol/lStandard Deviation 29.9
Metal on MetalMetal Ion Concentrations in BloodChromium 5 years19.1 nmol/lStandard Deviation 30.7
Metal on MetalMetal Ion Concentrations in BloodCobalt 6 months26.8 nmol/lStandard Deviation 25.1
Metal on MetalMetal Ion Concentrations in BloodCobalt 1 year41.4 nmol/lStandard Deviation 77.8
Metal on MetalMetal Ion Concentrations in BloodCobalt 2 years45.1 nmol/lStandard Deviation 45.5
Metal on MetalMetal Ion Concentrations in BloodCobalt 3 years57.5 nmol/lStandard Deviation 61.4
Metal on MetalMetal Ion Concentrations in BloodChromium 3 years-13.4 nmol/lStandard Deviation 8.2
Secondary

Oxford Hip Score

The Oxford Hip Score (OHS) is a patient-reported outcome measure that was developed to specifically assess the patient's perspective of outcome following THA. The OHS consists of twelve questions covering function and pain associated with the hip. To calculate the total score, each response is scored from 0 (worst outcome) to 4 (best outcome) and the sum of all 12 items is reported with a maximum of 48, representing the best score possible. The outcome score can be categorized as Excellent: \> 41; Good: 34 - 41; Fair: 27 - 33; Poor: \< 27.

Time frame: pre-operatively, 6 weeks post-operatively, 6 months post-operatively, 1, 2, 3, 4, 5 and 10 years post-operatively

Population: 2 patients were not included in analysis due to receiving a different articulation (not the study device). Other than that, the number of participants decreased over time due to several reasons, such as missing visits or lost to follow-up or withdrawn from the study for any reason.

ArmMeasureGroupValue (MEAN)Dispersion
Ceramic On MetalOxford Hip Score6 weeks postoperative37.3 units on a scaleStandard Deviation 6.8
Ceramic On MetalOxford Hip Score3 years postoperative46.4 units on a scaleStandard Deviation 3.5
Ceramic On MetalOxford Hip Score1 year postoperative46.0 units on a scaleStandard Deviation 3.8
Ceramic On MetalOxford Hip Score4 years postoperative46.8 units on a scaleStandard Deviation 2.7
Ceramic On MetalOxford Hip Score6 months postoperative45.0 units on a scaleStandard Deviation 4.3
Ceramic On MetalOxford Hip Score5 years postoperative46.1 units on a scaleStandard Deviation 3.1
Ceramic On MetalOxford Hip Score2 years postoperative46.6 units on a scaleStandard Deviation 2.7
Ceramic On MetalOxford Hip Score10 years postoperative44.0 units on a scaleStandard Deviation 7.9
Ceramic On MetalOxford Hip Scorepreoperative22.7 units on a scaleStandard Deviation 6.9
Metal on MetalOxford Hip Score10 years postoperative42.1 units on a scaleStandard Deviation 10.2
Metal on MetalOxford Hip Scorepreoperative22.1 units on a scaleStandard Deviation 7.3
Metal on MetalOxford Hip Score6 weeks postoperative39.0 units on a scaleStandard Deviation 6.7
Metal on MetalOxford Hip Score6 months postoperative44.8 units on a scaleStandard Deviation 5.2
Metal on MetalOxford Hip Score1 year postoperative46.1 units on a scaleStandard Deviation 4.1
Metal on MetalOxford Hip Score2 years postoperative45.9 units on a scaleStandard Deviation 4.5
Metal on MetalOxford Hip Score3 years postoperative45.9 units on a scaleStandard Deviation 4.5
Metal on MetalOxford Hip Score4 years postoperative46.0 units on a scaleStandard Deviation 4.2
Metal on MetalOxford Hip Score5 years postoperative45.9 units on a scaleStandard Deviation 3.8
Secondary

Survivorship

Survival of the implant based on the removal or intended removal of the device. The percentage of patients that still have the implant 10 years post-operative is presented here.

Time frame: 10 years post-op

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Ceramic On MetalSurvivorship99 Participants
Metal on MetalSurvivorship88 Participants
Secondary

Womac Score

The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC score) is a standardised patient reported outcome measure consisting of 24 items divided into 3 sub-sections: Pain (5 items), stiffness (2 items) and physical function or Activities of Daily Living; ADL (17 items). A higher score indicates a worse clinical outcome. The maximum score for each subsection is Pain: 20 - 0; Stiffness: 8 - 0; ADL: 68 - 0.

Time frame: pre-operatively, 6 weeks post-operatively, 6 months post-operatively, 1, 2, 3, 4, 5 and 10 years post-operatively

Population: 2 patients were not included in analysis due to receiving a different articulation (not the study device). Other than that, the number of participants decreased over time due to several reasons, such as missing visits or lost to follow-up or withdrawn from the study for any reason.

ArmMeasureGroupValue (MEAN)Dispersion
Ceramic On MetalWomac ScorePain 5 year post-operatively0.6 Units on a scaleStandard Deviation 1.6
Ceramic On MetalWomac ScoreStiffness 3 year post-operatively0.3 Units on a scaleStandard Deviation 0.9
Ceramic On MetalWomac ScorePain 2 year post-operatively0.3 Units on a scaleStandard Deviation 1.2
Ceramic On MetalWomac ScoreStiffness 4 year post-operatively0.2 Units on a scaleStandard Deviation 0.6
Ceramic On MetalWomac ScorePain 10 year post-operatively0.6 Units on a scaleStandard Deviation 1.9
Ceramic On MetalWomac ScoreStiffness 5 year post-operatively0.7 Units on a scaleStandard Deviation 1.2
Ceramic On MetalWomac ScorePain 6 weeks post-operatively2.9 Units on a scaleStandard Deviation 3
Ceramic On MetalWomac ScoreStiffness 10 year post-operatively0.7 Units on a scaleStandard Deviation 1.2
Ceramic On MetalWomac ScoreStiffness pre-operatively4.0 Units on a scaleStandard Deviation 1.3
Ceramic On MetalWomac ScoreADL pre-operatively32.1 Units on a scaleStandard Deviation 10.6
Ceramic On MetalWomac ScorePain 3 year post-operatively0.4 Units on a scaleStandard Deviation 1.1
Ceramic On MetalWomac ScoreADL 6 weeks post-operatively12.6 Units on a scaleStandard Deviation 9.4
Ceramic On MetalWomac ScoreStiffness 6 weeks post-operatively1.9 Units on a scaleStandard Deviation 1.3
Ceramic On MetalWomac ScoreADL 6 months post-operatively3.8 Units on a scaleStandard Deviation 5.4
Ceramic On MetalWomac ScorePain 1 year post-operatively0.5 Units on a scaleStandard Deviation 1.4
Ceramic On MetalWomac ScoreADL 1 year post-operatively3.2 Units on a scaleStandard Deviation 7.9
Ceramic On MetalWomac ScoreStiffness 6 months post-operatively0.6 Units on a scaleStandard Deviation 1
Ceramic On MetalWomac ScoreADL 2 year post-operatively2.7 Units on a scaleStandard Deviation 5.9
Ceramic On MetalWomac ScorePain 4 year post-operatively0.3 Units on a scaleStandard Deviation 1.1
Ceramic On MetalWomac ScoreADL 3 year post-operatively2.9 Units on a scaleStandard Deviation 6.8
Ceramic On MetalWomac ScoreStiffness 1 year post-operatively0.4 Units on a scaleStandard Deviation 0.8
Ceramic On MetalWomac ScoreADL 4 year post-operatively2.5 Units on a scaleStandard Deviation 5.1
Ceramic On MetalWomac ScorePain 6 months post-operatively0.8 Units on a scaleStandard Deviation 1.9
Ceramic On MetalWomac ScoreADL 5 year post-operatively3.5 Units on a scaleStandard Deviation 5.8
Ceramic On MetalWomac ScoreStiffness 2 year post-operatively0.2 Units on a scaleStandard Deviation 0.6
Ceramic On MetalWomac ScoreADL 10 year post-operatively5.1 Units on a scaleStandard Deviation 7.6
Ceramic On MetalWomac ScorePain pre-operatively10.5 Units on a scaleStandard Deviation 3.3
Metal on MetalWomac ScoreADL 10 year post-operatively5.6 Units on a scaleStandard Deviation 8.8
Metal on MetalWomac ScorePain pre-operatively11.5 Units on a scaleStandard Deviation 2.9
Metal on MetalWomac ScorePain 6 weeks post-operatively2.4 Units on a scaleStandard Deviation 2.8
Metal on MetalWomac ScorePain 6 months post-operatively0.7 Units on a scaleStandard Deviation 1.8
Metal on MetalWomac ScorePain 1 year post-operatively0.3 Units on a scaleStandard Deviation 1
Metal on MetalWomac ScorePain 2 year post-operatively0.5 Units on a scaleStandard Deviation 1.7
Metal on MetalWomac ScorePain 3 year post-operatively0.5 Units on a scaleStandard Deviation 1.6
Metal on MetalWomac ScorePain 4 year post-operatively0.6 Units on a scaleStandard Deviation 2
Metal on MetalWomac ScorePain 5 year post-operatively0.7 Units on a scaleStandard Deviation 1.8
Metal on MetalWomac ScorePain 10 year post-operatively0.6 Units on a scaleStandard Deviation 1.9
Metal on MetalWomac ScoreStiffness pre-operatively4.1 Units on a scaleStandard Deviation 1.5
Metal on MetalWomac ScoreStiffness 6 weeks post-operatively1.8 Units on a scaleStandard Deviation 1.3
Metal on MetalWomac ScoreStiffness 6 months post-operatively0.7 Units on a scaleStandard Deviation 1.2
Metal on MetalWomac ScoreStiffness 1 year post-operatively0.4 Units on a scaleStandard Deviation 0.9
Metal on MetalWomac ScoreStiffness 2 year post-operatively0.4 Units on a scaleStandard Deviation 0.9
Metal on MetalWomac ScoreStiffness 3 year post-operatively0.1 Units on a scaleStandard Deviation 0.6
Metal on MetalWomac ScoreStiffness 4 year post-operatively0.4 Units on a scaleStandard Deviation 1.1
Metal on MetalWomac ScoreStiffness 5 year post-operatively0.7 Units on a scaleStandard Deviation 1.3
Metal on MetalWomac ScoreStiffness 10 year post-operatively0.9 Units on a scaleStandard Deviation 1.4
Metal on MetalWomac ScoreADL pre-operatively33.7 Units on a scaleStandard Deviation 9.3
Metal on MetalWomac ScoreADL 6 weeks post-operatively11.1 Units on a scaleStandard Deviation 10
Metal on MetalWomac ScoreADL 6 months post-operatively5.0 Units on a scaleStandard Deviation 7.7
Metal on MetalWomac ScoreADL 1 year post-operatively3.8 Units on a scaleStandard Deviation 6.8
Metal on MetalWomac ScoreADL 2 year post-operatively3.4 Units on a scaleStandard Deviation 6.6
Metal on MetalWomac ScoreADL 3 year post-operatively2.7 Units on a scaleStandard Deviation 5.9
Metal on MetalWomac ScoreADL 4 year post-operatively2.7 Units on a scaleStandard Deviation 5.5
Metal on MetalWomac ScoreADL 5 year post-operatively4.3 Units on a scaleStandard Deviation 7.6

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026